Zeng H - Search Results

1

ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer.

Zeng H, Li T, Zhai D, Bi J, Kuang X, Lu S, Shan Z, Lin Y. Zeng H, et al. Int J Biol Sci. 2020 May 16;16(12):2084-2093. doi: 10.7150/ijbs.44204. eCollection 2020. Int J Biol Sci. 2020. PMID: 32549756 Free PMC article.

2

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.

Zhang Q, Lu S, Li T, Yu L, Zhang Y, Zeng H, Qian X, Bi J, Lin Y. Zhang Q, et al. Among authors: zeng h. J Exp Clin Cancer Res. 2019 Apr 25;38(1):173. doi: 10.1186/s13046-019-1156-5. J Exp Clin Cancer Res. 2019. PMID: 31023337 Free PMC article.

3

KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signaling.

Ye RY, Kuang XY, Zeng HJ, Shao N, Lin Y, Wang SM. Ye RY, et al. J Clin Lab Anal. 2020 Aug;34(8):e23315. doi: 10.1002/jcla.23315. Epub 2020 Mar 24. J Clin Lab Anal. 2020. PMID: 32207860 Free PMC article.

4

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer.

Li TF, Zeng HJ, Shan Z, Ye RY, Cheang TY, Zhang YJ, Lu SH, Zhang Q, Shao N, Lin Y. Li TF, et al. Cancer Cell Int. 2020 Apr 15;20:123. doi: 10.1186/s12935-020-01191-1. eCollection 2020. Cancer Cell Int. 2020. PMID: 32322170 Free PMC article.

5

Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer.

Ye R, AiErken N, Kuang X, Zeng H, Shao N, Lin Y, Liu P, Wang S. Ye R, et al. Among authors: zeng h. Oncogenesis. 2021 Sep 10;10(9):60. doi: 10.1038/s41389-021-00350-x. Oncogenesis. 2021. PMID: 34508066 Free PMC article.

6

HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.

Yu L, Wang C, Pan F, Liu Y, Ren X, Zeng H, Shi Y. Yu L, et al. Among authors: zeng h. Biomed Pharmacother. 2019 Oct;118:109361. doi: 10.1016/j.biopha.2019.109361. Epub 2019 Aug 23. Biomed Pharmacother. 2019. PMID: 31545274 Free article.

7

Tumor Suppressor Effect of RBMS3 in Breast Cancer.

Wang C, Wu Y, Liu Y, Pan F, Zeng H, Li X, Yu L. Wang C, et al. Among authors: zeng h. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211004921. doi: 10.1177/15330338211004921. Technol Cancer Res Treat. 2021. PMID: 33910421 Free PMC article.

8

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.

Wang J, Zeng H, Li H, Chen T, Wang L, Zhang K, Chen J, Wang R, Li Q, Wang S. Wang J, et al. Among authors: zeng h. Cell Physiol Biochem. 2017;43(2):717-732. doi: 10.1159/000481445. Epub 2017 Sep 27. Cell Physiol Biochem. 2017. PMID: 28946143 Free article.

9

Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.

Zeng H, Wang J, Chen T, Zhang K, Chen J, Wang L, Li H, Tuluhong D, Li J, Wang S. Zeng H, et al. Cancer Sci. 2019 Jan;110(1):289-302. doi: 10.1111/cas.13879. Epub 2018 Dec 13. Cancer Sci. 2019. PMID: 30443959 Free PMC article.

10

microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.

Zeng H, Wang L, Wang J, Chen T, Li H, Zhang K, Chen J, Zhen S, Tuluhong D, Li J, Wang S. Zeng H, et al. Arch Biochem Biophys. 2018 Aug 1;651:52-60. doi: 10.1016/j.abb.2018.05.018. Epub 2018 May 23. Arch Biochem Biophys. 2018. PMID: 29802821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,919 results

Search Page

Filters